Work Area: IP public policy

Latest content

Lack of mRNA tech transfer “a blessing in disguise” for WHO vaccine team, says Afrigen boss

Petro Terblanche tells IAM about the IP issues surrounding her team’s new replica of Moderna’s covid-19 vaccine

10 February 2022

The USPTO trials a possible solution to 101 patenting concerns

The agency’s Deferred Subject Matter Eligibility Response Pilot Program may be an attractive option for certain rights holders, write John Whetzel, Jon Wolfsberger and Dan Ovanezian

09 February 2022

Qualcomm, Nokia, Ericsson and other Western SEP superpowers are key geopolitical assets

The failure of policy makers in Washington DC, Brussels and elsewhere to view connectivity in the round could prove very costly further down the line

09 February 2022

Japanese ministry seeks industry input on SEP negotiation guidelines

Ericsson and Apple have already appeared before a study group mulling FRAND policy – other companies have until 8 March to submit comments on guidelines for good-faith dealing

07 February 2022

Michelle Lee joins Iancu, Kappos and Delrahim in criticising draft Biden FRAND policy

Eight former officials from the USPTO, DOJ Antitrust and NIST say draft would “severely tip the scales against SEP holders”

05 February 2022

Early comments mostly disapprove of US SEP/FRAND policy revision, but big fireworks are yet to come

Senator Tillis and Canon among early respondents, but major SEP licensors and Big Tech implementers haven’t weighed in yet

04 February 2022

Six reasons why 2022 could be pivotal for US biosimilars

A new wave of litigation, pending challenges to AbbVie’s patent thicketing strategy and looming legislation mean this year could be a turning point for biologics imitators.

27 January 2022

The political and practical case for patent transparency is clear, says former USPTO chief

David Kappos explains why he supports recent legislative moves to shine greater light on who owns what IP in the US

26 January 2022

USPTO’s subject matter eligibility pilot may save IP owners money, but still leaves a lot to be desired

Patent applicants may save legal costs by deferring responses on eligibility rejections, write Panitch Schwarze Belisario & Nadel partners Erin Dunston and Stephen Murray, but the USPTO programme won’t realise efficiency for examiners or fix the US patent eligibility law mess

25 January 2022

The EU’s UPC launch is imminent – here’s what IP strategists need to know

Companies must now make tough decisions about which rights to opt out of the new unified European patent system

25 January 2022

Get unlimited access to all IAM content